Phase I study of detoxified Escherichia coli J5 lipopolysaccharide (J5dLPS)/group B meningococcal outer membrane protein (OMP) complex vaccine in human subjects

Vaccine ◽  
2003 ◽  
Vol 21 (31) ◽  
pp. 4576-4587 ◽  
Author(s):  
Alan S Cross ◽  
Steven M Opal ◽  
John E Palardy ◽  
Joseph J Drabick ◽  
H.Shaw Warren ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Membrane Protein ◽  
Phase I ◽  
Outer Membrane ◽  
Outer Membrane Protein ◽  
Phase I Study ◽  
Human Subjects ◽  
Group B

scholarly journals A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of aPseudomonas aeruginosahybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers

2013 ◽  
Vol 10 (1) ◽  
pp. 170-183 ◽  
Author(s):  
Kerstin Westritschnig ◽  
Romana Hochreiter ◽  
Gerhard Wallner ◽  
Christa Firbas ◽  
Michael Schwameis ◽  
...  
Keyword(s):  
Membrane Protein ◽  
Phase I ◽  
Healthy Volunteers ◽  
Outer Membrane ◽  
Outer Membrane Protein ◽  
Phase I Study

Overexpression of Outer Membrane Protein A Is a Risk Factor for Mortality in Escherichia coli Bloodstream Infections

2019 ◽  
Author(s):  
Ángel Rodríguez-Villodres ◽  
Rocío Álvarez-Marín ◽  
María Antonia Pérez-Moreno ◽  
Andrea Miró-Canturri ◽  
Marco Durán Lobato ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Risk Factor ◽  
Membrane Protein ◽  
Outer Membrane ◽  
Outer Membrane Protein ◽  
Protein A ◽  
Bloodstream Infections ◽  
Outer Membrane Protein A
Sign in / Sign up

Export Citation Format

Share Document